NCT00016172View on ClinicalTrials.gov

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2000

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pegylated liposomal doxorubicin hydrochloride

DRUG

picoplatin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00016172 - ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter